Healthcare products
Child Health
Deficiency States and Supplementation
Dermatological Health
Pain treatment
Gastrointestinal Health
Genitourinary Health
Cardiorespiratory Health
Corticotherapy
Oral-Pharyngeal Health
Fluid Therapy
CNS Treatment
“Una rosa per no oblidar”
“Una rosa per no oblidar”
Once again, on the occasion of Sant Jordi’s Day, April 23rd, 2025, Laboratorios ERN has renewed its commitment to solidarity by joining the Fundació Alzheimer Catalunya. As we did in 2024, we wanted to convey a message of support to all people affected by Alzheimer’s disease. Each rose delivered represents much more than a flower: it is a living symbol of support, awareness and commitment, under the slogan “Una rosa per no oblidar” (A rose not to forget).
With this action, Laboratorios ERN reaffirms its willingness to go further, because although commitment, continuous improvement and the development of treatments are fundamental pillars of our work, we understand that true progress also involves building a more humane, empathetic and caring society.
This Sant Jordi 2025 we celebrate the culture, the bonds and the strength of a community committed to a more responsible, more conscious and more inclusive future.
noticias relacionadas
Ernamín at the 55th Congress of the Spanish Society of Nephrology
From October 16–18, the 55th edition of the Congress of the Spanish Society of Nephrology (SEN) took place in Oviedo. For the first time, and following the launch of Ernamín, ERN Laboratories participated as a collaborator in the event, with a stand in the commercial exhibition area and by organizing a technical forum featuring high-level […]
Incremental Drug Innovation: A Priority Focus for Laboratorios ERN
David Solanes López, General Manager of Laboratorios ERN, was appointed Academician of the Royal Academy of Pharmacy of Catalonia on October 6, 2025, in the industrial section. Solanes dedicated his induction speech to incremental innovation, an area closely linked to his professional career and to Laboratorios ERN’s commitment to developing solutions that improve patients’ lives. […]
FDA has approved intravenous fosfomycin for the treatment of cUTI
On October 22, 2025, the U.S. Food and Drug Administration (FDA) approved intravenous fosfomycin for the treatment of complicated urinary tract infections (cUTI). Laboratorios ERN expresses its satisfaction with the recent approval by the U.S. Food and Drug Administration (FDA) of intravenous fosfomycin for the treatment of patients aged 18 years and older with complicated […]
Laboratorios ERN collaborates with the Master’s in Logistics and Supply Chain Management at the University of Barcelona
The collaboration with the Institut de Formació Contínua–IL3 allows students to apply their knowledge to a real case in the pharmaceutical sector. Laboratorios ERN has strengthened its ties with the academic field through a collaboration with the Master’s in Logistics and Supply Chain Management at the Institut de Formació Contínua–IL3, part of the University of […]
“Una rosa per no oblidar”
Once again, on the occasion of Sant Jordi’s Day, April 23rd, 2025, Laboratorios ERN has renewed its commitment to solidarity by joining the Fundació Alzheimer Catalunya. As we did in 2024, we wanted to convey a message of support to all people affected by Alzheimer’s disease. Each rose delivered represents much more than a flower: […]